PUT/NOVO-NORDISK B/1400/0.1/20.09.24 Share Price

Warrant

DE000GQ4V6U3

Real-time BOERSE MUENCHEN 09:25:10 04/07/2024 BST
5.93 EUR +3.67% Intraday chart for PUT/NOVO-NORDISK B/1400/0.1/20.09.24
Current month+8.75%
1 month-10.49%
Date Price Change
04/07/24 5.93 +3.67%
03/07/24 5.72 +3.06%
02/07/24 5.55 +3.54%
01/07/24 5.36 +1.90%
28/06/24 5.26 -1.68%

Real-time BOERSE MUENCHEN

Last update July 04, 2024 at 09:25 am

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying NOVO NORDISK A/S
Issuer Goldman Sachs
WKN GQ4V6U
ISINDE000GQ4V6U3
Date issued 13/09/2023
Strike 1,400 kr
Maturity 20/09/2024 (79 Days)
Parity 10 : 1
Emission price 9.62
Emission volume N/A
Settlement Por diferencias
Currency EUR

Technical Indicators

Highest since issue 10.46
Lowest since issue 5.04
Delta0x
Omega 0.000000
Premium0x
Gearing2.16x
Moneyness 1.461
Difference Strike 439.2 kr
Difference Strike %+31.37%
Spread 0.05
Spread %0.84%
Intrinsic value 5.852
Present value 0.0532

Company Profile

Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Sector
-
More about the company

Ratings for Novo Nordisk A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Novo Nordisk A/S

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
967.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-1.59%
Consensus